Effectiveness of conventional drug therapy of plaque psoriasis in the context of consensus guidelines: a prospective observational study in 150 patients.

Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report. Ann Dermatol (2015) 0.89

The future of genetic studies of complex human diseases. Science (1996) 64.76

Genetic dissection of complex traits. Science (1994) 29.54

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol (1994) 10.17

Severe psoriasis--oral therapy with a new retinoid. Dermatologica (1978) 5.67

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet (2008) 5.32

Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics (2003) 3.39

Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol (1985) 2.74

TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol (2005) 2.29

Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum (2009) 2.06

The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet (1998) 1.94

Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol (1989) 1.65

Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol (2003) 1.47

Essential fatty acids in clinical dermatology. J Am Acad Dermatol (1989) 1.45

Sex hormones and the genesis of autoimmunity. Arch Dermatol (2006) 1.45

Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis (2005) 1.42

Ceramides and skin function. Am J Clin Dermatol (2003) 1.23

Measurement of involved surface area in patients with psoriasis. Br J Dermatol (1991) 1.23

Dietary fatty acids and inflammatory skin disease. Lancet (1989) 1.22

Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol (1992) 1.19

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12

Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol (2006) 1.05

Alcohol, smoking and psoriasis. Clin Exp Dermatol (2000) 1.04

A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J (2004) 1.02

Essential fatty acids and epidermal integrity. Arch Dermatol (1987) 1.00

Mediators of pruritus in psoriasis. Mediators Inflamm (2007) 0.99

Childhood psoriasis. Indian J Dermatol Venereol Leprol (2010) 0.96

Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol (2005) 0.96

Treatment goals in psoriasis. J Dtsch Dermatol Ges (2007) 0.95

Tazarotene--first of a new generation of receptor-selective retinoids. Br J Dermatol (1996) 0.94

Psoriasis. Lancet (1997) 0.93

The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis. Mol Diagn Ther (2010) 0.87

Burns area estimation-an error perpetuated. Burns (2004) 0.85

The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol (2000) 0.85

AAD consensus statement on psoriasis therapies. J Am Acad Dermatol (2003) 0.84

Study of the relationship between psoriasis and the polymorphic site C677T of methylenetetrahydrofolate reductase. Chin Med Sci J (2000) 0.84

Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol (2001) 0.84

Combination therapy with vitamin D analogues. Br J Dermatol (2001) 0.83

How genetic variation affects patient response and outcome to therapy for psoriasis. Expert Rev Clin Immunol (2010) 0.81

Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients. Transplant Proc (2006) 0.77

Pattern of skin and nail changes in chronic renal failure in Nepal: a hospital-based study. J Dermatol (2008) 0.80

Increased level of serum Homocysteine in vitiligo. J Clin Lab Anal (2011) 0.77

Lymphocutaneous sporotrichosis in an adolescent girl presenting as mycetoma. Int J Low Extrem Wounds (2012) 0.76

Generalized papular granuloma annulare. Indian Dermatol Online J (2012) 0.75

Role of caffeine in the management of androgenetic alopecia. Int J Trichology (2012) 0.75

Hypohidrotic ectodermal dysplasia. Int J Trichology (2012) 0.75

Pattern of Dermatophytoses in and Around Varanasi. Indian J Dermatol Venereol Leprol (2017) 0.75

Verrucous cell carcinoma arising from an underlying giant keratoacanthoma. Int J Low Extrem Wounds (2012) 0.75